[1]朱再生** 王跃平 童建勇 陈良佑 刘全启 罗荣利 徐礼臻 周鹏飞 朱子巍①.腹腔镜下保留神经膀胱全切联合抗反流新膀胱重建[J].中国微创外科杂志,2021,01(10):879-883.
 Zhu Zaisheng,Wang Yueping,Tong Jianyong,et al.Nervesparing Laparoscopic Radical Cystectomy With Antireflux Neobadder Reconstruction[J].Chinese Journal of Minimally Invasive Surgery,2021,01(10):879-883.
点击复制

腹腔镜下保留神经膀胱全切联合抗反流新膀胱重建()
分享到:

《中国微创外科杂志》[ISSN:1009-6604/CN:11-4526/R]

卷:
01
期数:
2021年10期
页码:
879-883
栏目:
临床研究
出版日期:
2021-10-25

文章信息/Info

Title:
Nervesparing Laparoscopic Radical Cystectomy With Antireflux Neobadder Reconstruction
作者:
朱再生** 王跃平 童建勇 陈良佑 刘全启 罗荣利 徐礼臻 周鹏飞 朱子巍①
(浙江大学医学院附属金华医院泌尿外科,金华321000)
Author(s):
Zhu Zaisheng Wang Yueping Tong Jianyong et al.
Department of Urology, Jinhua Hospital Affiliated to Zhejiang University School of Medicine, Jinhua 321000, China
关键词:
膀胱肿瘤回肠新膀胱尿流改道抗反流腹腔镜根治性膀胱全切神经保留
Keywords:
Bladder neoplasmsIleal neobladderUrinary diversionAntirefluxLaparoscopic radical cystectomyNervesparing
文献标志码:
A
摘要:
目的探讨腹腔镜下保留神经膀胱全切联合抗反流新膀胱重建术的应用价值。方法回顾性分析2016年1月~2019年6月39例膀胱癌行腹腔镜下保留神经的根治性膀胱全切+输尿管与储尿囊抗反流回肠新膀胱构建的资料。男37例,女2例,平均年龄59(47~70)岁。采用前列腺筋膜内切除技术(女性保留卵巢、子宫等生殖器官)行膀胱全切,回肠壁瓣联合输尿管拖入吻合抗反流新膀胱构建。随访6个月以上。结果手术均顺利完成。平均手术时间306(260~470)min,其中抗反流新膀胱构建时间43(35~55)min。估计失血量253(150~800)ml。术后平均随访22.5(6~43)月,1例术后33个月肿瘤相关死亡。术后30天内并发症10例(26%),术后30天后并发症3例(8%),均为ClavienDindo 1~2级,无膀胱输尿管反流和吻合口狭窄。完全控尿率术后1、6、12个月日间分别为72%(28/39)、97%(38/39)和100%(38/38),夜间分别为54%(21/39)、72%(28/39)和84%(32/38)。37例男性患者术前国际勃起功能指数5(International Index of Erectile Function 5,IIEF5)得分均≥15,术后6、12个月勃起功能恢复正常(IIEF5得分≥15)占比分别为46%(17/37)和57%(21/37)。 结论腹腔镜下保留神经的根治性膀胱切除+抗反流新膀胱术安全、有效,无严重并发症,短期肿瘤学结果和功能恢复较满意。
Abstract:
ObjectiveTo evaluate the clinical value of the nervesparing laparoscopic radical cystectomy with antireflux neobadder reconstruction.MethodsClinical data were retrospectively analyzed on 39 patients with bladder cancer who underwent nervesparing laparoscopic radical cystectomy with ureter and allantoic antireflux ileal neobladder reconstruction from January 2016 to June 2019. There were 37 males and 2 females, with an average of 59 (range, 47-70) years old. We conducted the nerve sparing with intrafascial laparoscopic radical cystectomy (for women, reproductive organs such as ovaries and uterus were retained) and the orthotopic ileal neobadder with the ileum valvuloplasty and pulling antireflux technique for ureterneobadder anastomosis. Followups lasted for more than 6 months.ResultsAll the operations were successfully completed. The mean operative time were 306 (range, 260-470) min, and the time for neobladder reconstruction was 43 (range, 35-55) min. The average intraoperative blood loss were 253 (range, 150-800) ml. Followup time was 22.5 (range, 6-43) months. There was 1 case of cancer related death at 33 months after surgery. The complication rates were 26% (10/39) within 30 days after the operation and 8% (3/39) after 30 days. All of the complications were ClavienDindo grade 1-2. Stricture of the ureteralneobladder anastomisis was not recorded. The continence rates at 1, 6 and 12 months postoperatively were 72% (28/39), 97% (38/39), and 100% (38/38) in daytime, and 54% (21/39), 72% (28/39), and 84% (32/38) in nighttime, respectively. The International Index of Erectile Function 5 (IIEF5) score in 37 male patients before operation was more than 15. The proportion of IIEF5>15 at 6 and 12 months after operation was 46% (17/37) and 57% (21/37), respectively.ConclusionsNervesparing laparoscopic radical cystectomy with antireflux neobadder reconstruction is feasible and safe, without serious complications. The shortterm oncology results and functional recovery are satisfactory.

参考文献/References:

[1]Alfred WJ,Lebret T,Compérat EM,et al.Updated 2016 EAU guidelines on muscleinvasive and metastatic bladder cancer. Eur Urol,2017,71(3):462-475.
[2]Tyritzis SI,Hosseini A,Collins J,et al.Oncologic,functional,and complications outcomes of robotassisted radical cystectomy with totally intracorporeal neobladder diversion.Eur Urol,2013,64(5):734-741.
[3]Parekh DJ,Reis IM,Castle EP,et al.Robotassisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR):an openlabel,randomised,phase 3,noninferiority trial.Lancet,2018,391(10139):2525-2536.
[4]Cacciamani GE,Marco VD,Sebben M,et al.Robotassisted vescica ileale padovana:a new technique for intracorporeal bladder replacement reproducing open surgical principles.Eur Urol,2018,65(16):1045-1051.
[5]Simone G,Papalia R,Misuraca L,et al.Robotic intracorporeal padua ileal bladder:surgical technique,perioperative,oncologic and functional outcomes.Eur Urol,2018,73(6):934-940.
[6]Djordjevic D,Vukovic M.Functional results of hautmann neobladder with chimney modification and wallace ureteroileal anastomosis:initial experience with 22 patients.Int Braz J Urol,2021,47(2):426-435.
[7]Hautmann RE,AbolEnein H,Lee CT,et al.Urinary diversion: how experts divert.Urology,2015,85:233-238.
[8]朱再生,施红旗,周鹏飞,等.腹腔镜根治性前列腺切除术个体化保留神经的探讨.中国微创外科杂志,2020,20(4):309-313.
[9]朱再生,徐礼臻,罗荣利,等.抗反流回肠壁瓣膜成形联合输尿管拖入合技术在原位新膀胱术中的应用与疗效.中华泌尿外科杂志,2015,36(9):672-675.
[10]Faba OR,Tyson MD,Artibani W,et al.Update of the ICUDSIU international consultation on bladder cancer 2018:urinary diversion.World J Urol,2019,37(1):85-93.
[11]Zhong H,Shen YF,Yao ZX.Longterm outcome of spiral ileal neobladder with orthotopic ureteral reimplantation.Int Urol Nephrol,2020,52(1):41-49.
[12]Demaegd L,Albersen M,Muilwijk T.Comparison of postoperative complications of ileal conduits versus orthotopic neobladders.Transl Androl Urol,2020,9(6):2541-2554.
[13]Gill I,Cacciamani G.LBA3 the changing face of urologic oncologic surgery from 2000-2018 (63 141 patients):impact of robotics.J Urol,2018,199:e577-e578.
[14]Yee CH,YuenChun J,Chan ES.Current evidence for robotic surgery in radical cystectomy.Turk J Urol,2021,47(Supp 1):S1-S8.
[15]Katayama S,Mori K,Pradere B,et al.Intracorporeal versus extracorporeal urinary diversion in robotassisted radical cystectomy:a systematic review and metaanalysis.Int J Clin Oncol,2021,26(9):1587-1599.
[16]Bochner BH,Dalbagni G,Marzouk KH,et al.Randomized trial comparing open radical cystectomy and robotassisted laparoscopic radical cystectomy:oncologic outcomes.Eur Urol,2018,74(4):465-471.
[17]Modh RA,Mulhall JP,Gilbert SM.Sexual dysfunction after cystectomy and urinary diversion.Nat Rev Urol,2014,11(8):445-453.
[18]Aminoltejari K,Black PC.Radical cystectomy:a review of techniques,developments and controversies.Transl Androl Urol,2020,9(6):3073-3081.
[19]Haberman K,Wittig K,Yuh B,et al.The effect of nervesparing robotassisted radical cystoprostatectomy on erectile function in a preoperatively potent population.J Endourol,2014,28(11):1352-1356.
[20]Collins JW,Hosseini A,Sooriakumaran P,et al.Tips and tricks for intracorporeal robotassisted urinary diversion.Curr Urol Rep,2014,15(11):457.
[21]朱再生,施红旗,周鹏飞,等.前列腺周围显微神经网三维解剖结构的观察.中华解剖与临床杂志,2019,24(6):596-602.
[22]朱再生,施红旗,周鹏飞,等.内镜技术下对前列腺周围神经网络的研究.中华男科杂志,2020,26(2):180-185.
[23]Refaai K,Sharafeldin MA,Elabbady A,et al.Perioperative outcomes of open retrograde extraperitoneal versus intracorporeal robotassisted radical cystoprostatectomy in men:a dualcenter comparative study.Clin Genitourin Cancer,2020,18(3):e315-e323.
[24]Tanneru K,Jazayeri SB,Kumar J,et al.Intracorporeal versus extracorporeal urinary diversion following robotassisted radical cystectomy:a metaanalysis,cumulative analysis,and systematic review.J Robot Surg,2021,15(3):321-333.
[25]Lobo N,Thurairaja R,Nair R,et al.Robotassisted radical cystectomy with intracorporeal urinary diversion:the new ‘gold standard’?Evidence from a systematic review.Arab J Urol,2018,16(3):307-313.
[26]Shigemura K,Yamanaka N,Imanishi O,et al.Wallace direct versus antireflux LeDuc uretemileal anastomosis:comparative analysis in modified studer orthotopic neobladder reconstruction.Int J Urol,2012,19(1):49-53.
[27]Minervini A,Semi S,Vittori G,et al.Current indications and results of orthotopie ileal neobladder for bladder cancer.Expert Rev Anticancer Ther,2014,14(4):419-430.
[28]Xu A,Li B,Li H,et al.Comparison of seromuscular tunnel and splitcuff nipple antireflux ureteroenteral anastomosis techniques in orthotopic taenia myectomy sigmoid neobladder:a prospective,randomized study.Urology,2013,81(3):669-674.

备注/Memo

备注/Memo:
基金项目:浙江省基础公益研究计划项目(LGF18H050006);浙江省金华市(社发类)科技重点研究项目(2016-3-004)**通迅作者,Email:zaishengzhu@126.com ①(浙江大学医学院研究生院,杭州310000)
更新日期/Last Update: 2022-02-08